Lb Pharmaceuticals LBRX
NASDAQ LBRX
$36.99 -0.29 (-0.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lb Pharmaceuticals (LBRX) Other Accumulated Expenses (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) recorded Other Accumulated Expenses of $798,000 in Q2 2026, up 204.6% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Other Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Lb Pharmaceuticals reported Other Accumulated Expenses of $515,000, down 35.6% from FY2024.

  • Across earlier years, Other Accumulated Expenses came in at $800,000 in FY2024.
  • Quarterly Other Accumulated Expenses has ranged from $262,000 in Q1 2026 to $868,000 in Q3 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $262,000 (Q1 2026), $515,000 (Q4 2025) and $868,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Lb Pharmaceuticals 1.06 Bn 1.06 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 798,000.00
Mar 31, 2026 262,000.00
Dec 31, 2025 515,000.00
Sep 30, 2025 868,000.00
Dec 31, 2024 800,000.00
API Access

Lb Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=LBRX&period=max&api_key=YOUR_API_KEY